Third Wave Technologies, Inc. Completes FDA Submissions for Its Two HPV Products

Published: Apr 28, 2008

MADISON, Wis.--(BUSINESS WIRE)--Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that the company has submitted the pre-market approval (PMA) applications for its two human papillomavirus, or HPV, testing products to the U.S. Food and Drug Administration.

Back to news